日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Physiologically based pharmacokinetic model of sodium-glucose cotransporter 2 inhibitors predicted pharmacokinetics and pharmacodynamics to explore dosage regimen for patients with type 2 diabetes mellitus and renal insufficiency

基于生理的钠-葡萄糖协同转运蛋白2抑制剂药代动力学模型预测了其药代动力学和药效学，以探索2型糖尿病合并肾功能不全患者的给药方案。

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1520268
Guo, Guimu; Ke, Meng; Xu, Jianwen; Wu, Wanhong; Chen, Jiarui; Ke, Chengjie; Huang, Pinfang; Lin, Cuihong
糖尿病
代谢
发表日期：2025
文献求助 收藏

Impact of the ENPP1 mutation on bone mineralization and ectopic calcification: evidence from in vitro and in vivo models.

ENPP1 突变对骨矿化和异位钙化的影响：来自体外和体内模型的证据

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2025.1566392
Wu Wanhong, Liu Luna, Shi Yingzhou, Zhang Yidan, Qiu Renyuan, Yan Fang
骨科研究
发表日期：2025
文献求助 收藏

dentification and characterization of novel PAX4 variants in patients with suspected MODY9

对疑似MODY9患者中新的PAX4变异体进行鉴定和表征

期刊:Bmj Open Diabetes Research & Care
影响因子:4.1
doi:10.1136/bmjdrc-2025-005375
Chen, Xinyu; Tian, Yang; Wu, Wanhong; Liu, Luna; Wu, Huixiao; Zhang, Yidan; Suo, Ning; Xu, Chao
发表日期：2025
文献求助 收藏

Toward Precision Dosing of Lamotrigine During Pregnancy: Physiologically Based Pharmacokinetic Modeling and Simulation

妊娠期拉莫三嗪精准给药：基于生理的药代动力学建模与模拟

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.70007
Qian, Yudie; Wu, Wanhong; Ke, Chengjie; Liu, Siting; Chen, Jiarui; Chen, Yuying; Guo, Xianzhong; Lin, Weiwei
发表日期：2025
文献求助 收藏

Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets

以蛋白质为中心的组学分析揭示了与非病毒性肝病相关的循环补体作为潜在的治疗靶点。

期刊:Clinical and Molecular Hepatology
影响因子:16.9
doi:10.3350/cmh.2023.0343
Shi, Yingzhou; Dong, Hang; Sun, Shiwei; Wu, Xiaoqin; Fang, Jiansong; Zhao, Jianbo; Han, Junming; Li, Zongyue; Wu, Huixiao; Liu, Luna; Wu, Wanhong; Tian, Yang; Yuan, Guandou; Fan, Xiude; Xu, Chao
毒理研究
微生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

The health and economic burden of rare endocrine disease: Often ignored, always important

罕见内分泌疾病带来的健康和经济负担：常被忽视，却始终至关重要

期刊:Journal of Global Health
影响因子:4.3
doi:10.7189/jogh.14.04249
Liu, Luna; Shi, Yingzhou; Li, Yuchen; Wu, Wanhong; Tian, Yang; Fan, Xiude; Xu, Chao
发表日期：2024
文献求助 收藏

The health-care utilization and economic burden in patients with genetic skeletal disorders

遗传性骨骼疾病患者的医疗保健利用情况和经济负担

期刊:Orphanet Journal of Rare Diseases
影响因子:3.5
doi:10.1186/s13023-024-03102-3
Liu, Luna; Shi, Yingzhou; Fan, Xiude; Yao, Yangyang; Wu, Wanhong; Tian, Yang; Wu, Huixiao; Li, Zongyue; Wang, Yanzhou; Xu, Chao
发表日期：2024
文献求助 收藏

Geographical distribution and species variation of gut microbiota in small rodents from the agro-pastoral transition ecotone in northern China

中国北方农牧交错带小型啮齿动物肠道菌群地理分布及种类变异

期刊:Ecology and Evolution
影响因子:2.3
doi:10.1002/ece3.11084
Yongzhen Wu, Taoxiu Zhou, Chen Gu, Baofa Yin, Shengmei Yang, Yunzeng Zhang, Ruiyong Wu, Wanhong Wei
免疫
发表日期：2024
文献求助 收藏

The impact of metabolic overweight/obesity phenotypes on unplanned readmission risk in patients with COPD: a retrospective cohort study

代谢性超重/肥胖表型对慢性阻塞性肺疾病患者非计划再入院风险的影响：一项回顾性队列研究

期刊:Frontiers in Physiology
影响因子:3.4
doi:10.3389/fphys.2023.1290611
Tian, Yang; Liu, Luna; Li, Yuchen; Fan, Xiude; Wu, Wanhong; Shi, Yingzhou; Jiang, Jie; Yuan, Zinuo; Dong, Hang; Li, Huijie; Xuan, Qiuhui; Xu, Chao
肥胖
慢性阻塞性肺疾病
代谢
发表日期：2023
文献求助 收藏

Application of Physiologically Based Pharmacokinetic Modeling to Predict Maternal Pharmacokinetics and Fetal Exposure to Oxcarbazepine

应用基于生理的药代动力学模型预测母体药代动力学和胎儿对奥卡西平的暴露量

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics14112367
He, Lixia; Ke, Meng; Wu, Wanhong; Chen, Jiarui; Guo, Guimu; Lin, Rongfang; Huang, Pinfang; Lin, Cuihong
发表日期：2022
文献求助 收藏